Catalio Capital Management β Full Portfolio
19 tracked investments Β· listed companies and verified rows first
Iambic is a clinical-stage life science and technology company that develops novel medicines using an AI-driven drug discovery and development platform.
AI & Machine LearningBiotechDeep TechSan Diego, US
Tom Miller(Co-Founder & CEO)inFred Manby(Co-Founder & CTO)inThomas Miller(Founder)inNeil Josephson(Chief Medical Officer)inPete Olson(Chief Scientific Officer)inMichael Secora(Chief Financial Officer and Chief Corporate Development Officer)in
Co-investorsAbingworthAscenta CapitalAlumni VenturesCatalio Capital Management, LPCoatue ManagementEisai Innovation, Inc.+4 more
Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space.
BiotechHealthtechMedical Devices
Co-investorsArboretum VenturesMaverick Ventures IsraelVisionary VenturesJohnson & Johnson Innovation β JJDCLifeSci Venture PartnersSequoia Capital+1 more
Spiral Therapeutics is a clinical-stage pharmaceutical company developing therapies for balance disorders and hearing loss using its Minimally Invasive Cochlear System (MICS) drug delivery platform.
BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US
Hugo Peris(Founder & CEO)Eugene de Juan(Executive Officer, Director)Lawrence Fritz(Director)
BoardWARREN THALER(Director)JEAN-FREDERIC PAULSEN(Director)Guy Nohra(Director)
Co-investorsAlta Partners
Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US
Max Mumbach(Founding Scientist, Target Discovery)Jeffrey Verboon(Founding Scientist, Computational Biology)Ansu Satpathy(Founder)Kevin Parker(Chief Executive Officer)Kevin Parker, PhD(Chief Executive Officer, Board Director; co-founder)Ansuman Satpathy, MD, PhD(Co-founder; Board Director)
Co-investors8VCAndreessen HorowitzArtis VenturesGlobal BioAccess FundHAWKTAILPfizer Venture Investments+6 more
Character Bio is a precision medicine company that integrates genomics, longitudinal clinical data, imaging, and AI-based biomarker analysis to identify genetic drivers of progressive polygenic eye diseases such as age-related macular degeneration and glaucoma.
AI & Machine LearningBiotechDigital HealthJersey City, US
Cheng Zhang(Executive Officer, Director)
BoardVivek Garipalli(Director)Nick Olsen(Director)Peter DiLaura(Director)
Co-investorsaMoonCantos VenturesCatalio Capital Management, LPDuke Capital PartnersLifeforce CapitalSanofi Ventures+3 more
BiotechJersey City, US
Henry Rath(Executive Officer)Susan Orr(Executive Officer)Clarke Atwell(Executive Officer, Director)Stephen Brady(Executive Officer, Director)Michael Dybbs(Director)Matt Hobson(Director)
Co-investorsNovo HoldingsSamsara BioCapitalSofinnova Ventures
Clasp Therapeutics develops off-the-shelf precision T cell engagers (its proprietary pHLΠre molecules) that target mutant peptide-HLA complexes displayed on cancer cells, directing T cells to destroy tumors carrying common driver mutations such as KRas.
BiotechHealthtechCambridge, US
Co-investorsCatalio Capital Management, LPCure VenturesVivo CapitalNovo HoldingsThird Rock Ventures
Cortex Robot builds datasets for embodied AI and robotics, including egocentric video data from real workplaces and robot trajectories for training physical intelligence systems.
Advanced ManufacturingAI & Machine LearningData & InfrastructureRoboticsSan Francisco, US
Lucas Ngoo(Founder)in
Co-investorsTranspose Platform ManagementY CombinatorGV (Google Ventures)Lux Capital
BiotechCambridge, US
Gabriel Kwong(Executive Officer)Sirshendu Roopom Banerjee(Executive Officer)
BoardTheresia Guow(Director)Amy Schulman(Director)inStan Lapidus(Director)
Co-investorsGreatPoint VenturesAcrew CapitalAspect VenturesDns CapitalNew Leaf Venture PartnersPolaris Partners+2 more
Imbria Pharmaceuticals develops novel cardiovascular disease treatments that target cardiac energy metabolism, with a lead drug candidate, ninerafaxstat, in clinical trials for non-obstructive hypertrophic cardiomyopathy.
BiotechDigital Health
Alvin Shih(CEO)Albert M. Kim(Chief Medical Officer)
Co-investorsAN Venture PartnersRA CapitalSanofi VenturesSV Health Investors
Chronus (at imperative.com) offers an AI-assisted mentoring and connection platform that matches employees for guided conversations covering career development, mentorship, community building, and change adoption.
Future of WorkHR TechSaaSNew York, US
Co-investorsVoyager CapitalAlly Bridge GroupBain Capital Life Sciences
Insightec develops Exablate Neuro, an MRI-guided focused ultrasound platform that treats Essential Tremor and tremor-dominant Parkinson's Disease through an incision-free outpatient procedure.
HealthtechMedical DevicesTirat Carmel
Roni Karie(Vice President - Finance)Shirel Aroshase(Vice President - Human Resources)Eyal Zadicario(General Manager)Menashe Frank(Vice President - Legal)Jun (Jim) Tao(Chief Operating Officer)Maurice R. Ferre(Chairman and Chief Executive Officer)
Co-investorsCatalio Capital Management, LPExigent CapitalGEOCJazzya InvestmentsKoch Disruptive TechnologiesKrillion Ventures+7 more
Lassen Therapeutics is a biotechnology company developing therapeutics targeting IL-11, with a pipeline focused on immune and fibrotic diseases.
Biotech
David King(Co-Founder & CSO)Maria Fardis(CEO)Cadmus C. Rich(Chief Medical Officer)Elaine Stracker(General Counsel)
Co-investorsAlta PartnersCatalio Capital Management, LPDC Investment PartnersLongitude CapitalLongwood FundBiotechnology Value Fund+2 more
NextPoint Therapeutics is a biotech company developing first-in-class immuno-oncology therapies, including a T cell engager, an antibody drug conjugate, and a checkpoint inhibitor, using a biomarker-driven approach.
BiotechDeep TechDigital HealthHealthtechMedical DevicesAustin, US
Gordon Freeman(Scientific Founder)XingXing Zang(Scientific Founder)Ivan Cheung(Chief Executive Officer)Leena Gandhi(Chief Medical Officer)Tatiana Novobrantseva(Chief Scientific Officer)Axel Hoos(Director)
Co-investorsCatalio Capital Management, LPMPM BioImpactSanofi VenturesInvusLeaps by BayerSixty Degree Capital
Ratio Therapeutics develops radiopharmaceuticals for oncology, working on targeted radiochemistry, discovery, and preclinical and clinical development.
BiotechHealthtechMedical DevicesBoston, US
John W. Hoppin(Executive Officer, Director)John Babich(Director, President & Chief Scientific Officer)Marc Becker(Chief Financial and Operating Officer)Scott MacDonald(Executive Officer)William Cowan(Director)Susan Whoriskey(Director)
Somethings is a mobile app that connects teens with Certified Peer Specialists who have overcome their own mental health challenges and provide chat and call support supervised by clinicians.
Digital HealthMental HealthWellness & Fitness
Co-investorsCoalition OperatorsTau VenturesGeneral CatalystTAU Ventures
Star Therapeutics develops treatments aimed at addressing real-world patient needs.
BiotechSouth San Francisco, US
Adam Rosenthal(Founder & CEO)Jason Hafler(Director)Nancy Stagliano(Director)Michelle Carpenter(Executive Officer)Carl Gordon(Director)Matthew Fust(Director)
Co-investorsFrazier Life SciencesOrbiMedRA CapitalSanofi VenturesSofinnova VenturesAgent Capital+8 more
Syndeio Biosciences is a synapse-focused biotech developing precision neurotherapeutics for neuropsychiatric, mental health, and cognitive disorders such as depression and Alzheimer's.
AI & Machine LearningBiotechDigital Health
Co-investorsEvolution VC PartnersTenmilePalo Santo
Visby makes a handheld PCR diagnostic device for at-home testing of common curable STIs including chlamydia, gonorrhea, and trichomoniasis, delivering results in about 30 minutes.
ConsumerDigital HealthMedical Devices
Adam de la Zerda(Founder)in
Co-investorsKhosla Ventures+ND CapitalArtiman VenturesPitango
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.